Expression of the receptors of VEGF and the influence of extract of Ginkgo biloba after cisternal injection of autologus arterial hemolysate in rats

Clinical Hemorheology and Microcirculation

Volumn 34, Issue 1-2, 2006, Pages 117-124

  Sun, Bao Liang ^a   Xia, Zuo Li ^a   Hu, Dong Mei ^a   Niu, Jing Zhong ^a   Yuan, Hui ^a   Ye, Wen Jing ^b   Wang, Xin Cheng ^b   Zhang, Su Ming ^c  

^a Department of Neurology   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Ginkgo biloba (EGb); Receptor; Secondary cerebral ischemia; Subarachnoid hemorrhage; Vascular endothelial growth factor (VEGF)

Indexed keywords

GINKGO BILOBA EXTRACT; MESSENGER RNA; SODIUM CHLORIDE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CISTERNA MAGNA; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; GINKGO BILOBA; HEMOLYSATE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; RAT STRAIN; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE;

ANIMALS; ARTERIES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GINKGO BILOBA; PLANT EXTRACTS; RATS; RATS, WISTAR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RNA, MESSENGER; SUBARACHNOID HEMORRHAGE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33644810138     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. E.M. Manno, Subarachnoid hemorrhage, Neurol. Clin. 22 (2004), 347-366.
2. J. Sen, A. Belli, H. Albon, L. Morgan, A. Petzold and N.J. Kitchen, Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage, Lancet Neurol. 2 (2003), 614-621.
3. B.L. Sun, S.M. Zhang, Z.L. Xia, M.F. Yang, H. Yuan, J. Zhang and R.J. Xiu, The effects of nimodipine on regional cerebral blood flow, brain water and electrolyte contents in rats with subarachnoid hemorrhage, Clin. Hemorheol. Microcirc. 29 (2003), 337-344.
4. G. Grasso, An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage, Brain Res. Brain Res. Rev. 44 (2004), 49-63.
5. E.F. Wijdicks, D.F. Kallmes, E.M. Manno, J.R. Fulgham and D.G. Piepgras, Subarachnoid hemorrhage: neurointensive care and aneurysm repair, Mayo Clin. Proc. 80 (2005), 550-559.
6. T. Tammela, B. Enholm, K. Alitalo and K. Paavonen, The biology of vascular endothelial growth factors, Cardiovasc. Res. 65 (2005), 550-563.
7. D. Ribatti, The crucial role of vascular permeability factor/vascular endothelial growth factor in angiogenesis: a historical review, Br. J. Haematol. 128 (2005), 303-309.
8. M.J. McGirt, J.R. Lynch and R. Blessing, Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage, Neurosurg. 51 (2002), 1128-1135.
9. B.L. Sun, J. Zhang, X.C. Wang, Z.L. Xia, M.F. Yang, S.M. Zhang, W.J. Ye and H. Yuan, Effects of extract of Ginkgo biloba on spasms of the basilar artery and cerebral microcirculatory perfusion in rats with subarachnoid hemorrhage, Clin. Hemorheol. Microcirc. 29 (2003), 231-238.
10. B.L. Sun, Z.L. Xia, M.F. Yang and P.M. Qiu, Effects of Ginkgo biloba extract on somatosensory evoked potential, nitric oxide levels in serum and brain tissue in rats with cerebral vasospasm after subarachnoid hemorrhage, Clin. Hemorheol. Microcirc. 23 (2000), 139-144.
11. T. Asano, Oxyhemoglobin as the principal cause of cerebral vasospasm: a holistic view of its actions, Crit. Rev. Neurosurg. 9 (1999), 303-318.
12. Y. Sun, K. Jin, L. Xie, J. Childs, X.O. Mao, A. Logvinova and D.A. Greenberg, VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia, J. Clin. Invest. 111 (2003), 1843-1851.
13. P. Pichiule, F. Agani, J.C. Chavez, K. Xu and J.C. LaManna, HIF-1 alpha and VEGF expression after transient global cerebral ischemia, Adv. Exp. Med. Biol. 530 (2003), 611-617.
14. J. Hai, S.T. Li, Q. Lin, Q.G. Pan, F. Gao and M.X. Ding, Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain, Neurosurg. 53 (2003), 963-970.
15. K.L. Jin, X.O. Mao, T. Nagayama, P.C. Goldsmith and D.A. Greenberg, Induction of vascular endothelial growth factor receptors and phosphatidylinositol 3′-kinase/Akt signaling by global cerebral ischemia in the rat, Neurosci. 100 (2000), 713-717.
16. F. Lennmyr, K.A. Ata, K. Funa, Y. Olsson and A. Terent, Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat, J. Neuropathol. Exp. Neurol. 57 (1998), 874-882.
17. E. Storkebaum, D. Lambrechts and P. Carmeliet, VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection, Bioessays 26 (2004), 943-954.
18. Y. Saitoh, A. Kato, Y. Hagihara, Y. Kaned and T. Yoshimine, Gene therapy for ischemic brain diseases, Curr. Gene Ther. 3 (2003), 49-58.
19. F.Y. Sun and X. Guo, Molecular and cellular mechanisms of neuroprotection by vascular endothelial growth factor, J. Neurosci. Res. 79 (2005), 180-184.
20. B.L. Sun, S.M. Zhang, Z.L. Xia, M.F. Yang, P.M. Qiu and H. Yuan, Role of nitric oxide in cerebral vasospasm-induced neuronal damage in rats, Chin. J. Pathophysiol. 20 (2004), 76-79.
21. B.L. Sun, S.M. Zhang, Z.L. Xia, M.F. Yang, P.M. Qiu and H. Yuan, Effect of extrinsic L-arginine on cerebral vasospasm in rats, Chin. Hosp. Pharm. 23 (2003), 260-262.
22. W.M. Clark, L.G. Rinker, N.S. Lessov, S.L. Lowery and M.J. Cipolla, Efficacy of antioxidant therapies in transient focal ischemia in mice, Stroke 32 (2001), 1000-1004.
23. H.J. Gertz and M. Kiefer, Review about Ginkgo biloba special extract EGb 761 (Ginkgo), Curr. Pharm. Des. 10 (2004), 261-264.